INTRODUCTION
Innate lymphoid cells (ILCs) are a family of three groups (ILC1, ILC2, and ILC3) that rapidly respond to inflammatory signals by producing cytokines also involved in tissue homeostasis (Seillet et al., 2014) . Group 1 is defined as distinct from conventional NK (cNK) cells and requires T-bet for its lineage specification (Bernink et al., 2013; Daussy et al., 2014; Fuchs et al., 2013; Klose et al., 2014) . Group 2 expresses the transcription factors GATA3 and RORa (Hoyler et al., 2012; Klein Wolterink et al., 2013; Wong et al., 2012) . Group 3 developmentally depends on the transcription factor RORgt and is composed of several distinct populations that emerge during ontogeny. During fetal life, only lymphoid tissue inducer (LTi) cells are present, and other ILC3 subsets appear after birth. LTi cells and their precursors are found in the fetal liver (FL) (Mebius et al., 2001) . They are essential for the generation of secondary lymphoid tissues (Eberl et al., 2004) and express Rorc, which controls interleukin (IL)-17A and IL-22 production. LTi cells are CCR6 + c-Kit + IL-7Ra hi cells and are referred to as LTi 4 and LTi 0 , depending on the expression of CD4 (Klose et al., 2013; Sawa et al., 2010) . All ILCs initially derive from the common lymphoid progenitor (CLP) (Cherrier et al., 2012; Mebius et al., 2001; Possot et al., 2011; Wong et al., 2012; Yang et al., 2011b) . A common feature to ILC commitment is the requirement for the transcriptional repressor regulator ID2 (Hoyler et al., 2012; Moro et al., 2010; Satoh-Takayama et al., 2010; Yokota et al., 1999) , an inhibitor of E protein transcription factors. The current scheme of ILC development describes the global ILC (GILP) precursor as NFIL3 + TOX + , which further becomes the ID2 hi common helper ILC precursor (CHILP) when cNK cell potential is lost (Constantinides et al., 2014; Klose et al., 2014; Seehus et al., 2015; Xu et al., 2015) . After acquisition of Zbtb16 expression, CHILP loses the capacity to differentiate into LTi cells, showing that LTi precursors stand at the bifurcation between GILP and CHILP (Constantinides et al., 2014) . The Notch pathway is conserved and involved in many biological processes (Hori et al., 2013) . Activation of Notch receptors promotes their proteolysis, resulting in the release of the Notch intracellular domain (NICD), which enters the nucleus as a cotranscriptional factor with the DNA-binding protein RBP-Jk (Recombination signal sequence-Binding Protein Jk chain) (Hori et al., 2013) . The activation of this canonical Notch signaling pathway is known to regulate the transcription of target genes (Iso et al., 2003) . During hematopoiesis, the Notch pathway acts as a cell-fate switch between the lymphoid and myeloid lineages (Oh et al., 2013) . Notch1 is essential for T cell development at the expense of B cell development Pui et al., 1999; Sambandam et al., 2005) . Notch2 signaling is crucial to marginal zone B cells (Saito et al., 2003; Tanigaki et al., 2002) and to the development of CD11b + classical dendritic cells (cDCs) in spleen and intestine (Lewis et al., 2011; Satpathy et al., 2013) . The relevance of the Notch pathway along ILC differentiation is still unresolved. Studies have supported the idea that the Notch pathway is necessary at a different branch point of adult ILC differentiation (Klose et al., 2013; Lee et al., 2012; Rankin et al., 2013) . We recently suggested that Notch, although active, is not essential to the development of FL LTi cells (Possot et al., 2011) , which was challenged by a report indicating that the Notch pathway blocks LTi development just before the expression of RORgt (Cherrier et al., 2012) . Because both studies were performed in vitro, we developed mouse models to decipher the in vivo involvement of the Notch pathway during fetal LTi cell commitment and differentiation.
To delete the Notch pathway from the earliest stage of lymphoid progenitors, we used the Il7r
Cre mouse (Schlenner et al., 2010) (Kondo et al., 1997) and is important for ILC development Schmutz et al., 2009; Yoshida et al., 2002) . Notch2 was previously shown to be more highly expressed in ILC precursors than Notch1 (Possot et al., 2011; Cherrier et al., 2012) . In these mouse models, all the lymphoid progenitors and their progeny undergo Notch loss (or gain) of function. In parallel, we generated a double reporter Id2 yfp/+
Cxcr6
gfp/+ mouse to define diverse FL ID2 + fractions of ILC precursors depending on the repartition of a 4 b 7 , CXCR6, IL-18R1, and Thy1.2. We determined their hierarchy during ILC development and examined their equivalent in Notch-deficient embryos.
By targeting RBP-Jk in lymphoid precursors, we report that canonical Notch signaling is unnecessary for LTi cell commitment and differentiation, and we showed that sustained Notch signaling is not blocking their development but rather promoting T cell development over any other lineages. In the periphery, Notch signaling modulates IL-22 levels in fetal mesenteric lymph node (FmLN Cre/+ embryos, the mean fluorescence intensity (MFI) for the IL7Ra was lower than in control Il7r +/+ embryos ( Figure 1C ). We quantified their levels of Il17a, Il17f, and Il22 transcripts. While Il17a and Il17f levels were identical, Il22 mRNA levels were significantly higher in lymph node LTi cells after Rbpj deletion (Figure 1G) . Moreover, in Notch-deficient mice, Peyer's patches formed in normal numbers ( Figure 1H ), and all types of peripheral lymph nodes were present, indicating that LTi cells' function as inducer cells is independent of Notch activation.
In peripheral LTi cells (FS and FmLN) , Notch2 is expressed in higher amounts than Notch1 ( Figure S1D ). The inactivation of Notch signaling significantly interferes with the Notch2 levels in lymphoid cells from the FmLNs ( Figure S1D ). No differences were observed for the frequency and total numbers of peripheral lymphoid progenitors from Il7r cre/+ Notch2 fl/fl and Il7r cre/+ Notch2 fl/+ embryos ( Figure 1I ). The distribution and phenotype of RORgt + LTi in both FS and FmLNs were also similar, indicating that these progenitors develop and migrate independently of Notch2 ( Figures S1E and 1F ).
In conclusion, although not required for the development, migration, and the functional property of secondary tissue Data are representative of at least three independent experiments (A, B, C, and E) (n R 4), three pooled independent experiments (D, F, and I) (n = 3), three independent experiments (G), or at least five pooled independent experiments (H) (n R 5). In (D), (F), and (I), each dot represents a single experiment. Statistical data show mean ± SEM. *p < 0.05 (unpaired Student's t test). N.S., not significant. See also Figure S1 . Figure 2D ). aLP1 expressed intermediate levels of ID2, suggesting that the upregulation of ID2 begins within this subset. After short-term cultures, CLPs are able to give rise to both aLP1 and aLP2 fractions ( Figure 2E ). ID2 expression is detected in few aLP1 cells and in most aLP2 cells. Also, aLP2 expressed high levels of YFP contrary to the aLP1 fraction. In conclusion, aLP1 is a transitional stage between CLP and aLP2 with few ID2 lo progenitors. ID2 hi cells are highly represented in aLP2 (84.6%).
In embryos with constitutive Notch signaling activation, no a 4 b 7 + RORgt + cells could be detected in the FL ( Figure 2F ). Cells harboring a CLP phenotype were decreased, whereas those presenting an aLP2 phenotype were increased ( Figure 2G ). However, the aLP2 subset in Il7r
Cre Figure 3B ). However, concerning the aLP2 subset, the distribution of IL7Ra hi cells may be different after notch disruption ( Figure 3B ). Numbers of lymphoid progenitors were consistently lower in mice with only one allele of the IL-7Ra (Il7r Cre/+ ), although the percentages of Lin Figure 3C ). We sorted the different precursor subsets ( Figure S2A) and show that the level of Notch1 transcripts decreases as differentiation into ILCs progresses from the CLP stage to the aLP2 stage, whereas Notch2 transcripts reach maximal levels in aLP2 cells ( Figure S2B ). Because Notch2, but not Notch1, is highly expressed in ILC progenitors, and as non-canonical Notch signaling might operate in the absence of RBP-Jk, we analyzed ILC development after Notch2 deletion in lymphoid progenitors. Neither the phenotype, percentage, and numbers of FL lymphoid precursors (Figures S2C and S2D) nor T cell development (Figure S2E) were affected by the Notch2 deletion.
Short-term cultures were performed to analyze the capacity of lymphoid progenitors to upregulate a 4 b 7 in the absence or presence of Notch signaling ( Figure 3D ). After 48 hr on OP9 stroma, around 35% of cultured CLPs expressed a 4 b 7 regardless of the genotypes. Upregulation of a 4 b 7 was also observed on OP9-DL4 for all genotypes ( Figure 3E ). Consistent with Notch deficiency, we observed the development of CD19 + B cells on Data are representative of at least three independent experiments-(F), (G), and (H) from single FL each and (A), (B), and (D) from pooled organs-or three independent experiments (C) (n R 3 for each group), or three independent experiments with at least two wells per experiment (E). Statistical data show mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0. The differentiation potential of aLP1 and aLP2 from Notchdeficient or Notch-competent embryos was tested after 8 days of culture. As expected, T cell differentiation potential was lost in Notch-deficient aLP1 cells, but not in their littermate controls, and the NK cell progeny increased proportionally to the loss of Rbpj alleles ( Figure S2F) Figure 3F ). Dtx1 and Nrarp were not expressed (data not shown). Except for Rora (only found in aLP2) and Hes1 (also expressed in CLPs), the expression of most transcription factors analyzed begins at the aLP1 stage ( Figure 3F ). No statistical difference was detected in the expression levels of Id2, Tcf7, Gata3 and Rora after the inactivation of the Notch pathway. We noticed a tendency for Hes1 and Tox mRNA levels to decrease after disruption of the Notch pathway ( Figure 3F ).
In conclusion, the inactivation of the Notch pathway did not alter the capacity of FL lymphoid precursors to differentiate into ILCs. The Notch signaling pathway appears to be dispensable to generate and maintain the phenotype and distribution of FL lymphoid progenitors, including RORgt + LTip. However, it is probably implicated during the differentiation of specific ILC subsets, since some ILC-specific transcription factors tend to be decreased after Notch disruption. Hence, frequency and heterogeneity of aLP2 subsets may vary after disruption of the Notch pathway.
aLP2 Cells Have Heterogeneous Transcriptional Profiles at the Single-Cell Level The heterogeneity of ILC progenitors drove us to develop a single-cell transcriptional analysis assay using the Biomark HD system to assess the effect of Notch signaling. The linearity, specificity, and efficiency of primers have been thoroughly tested (Figures S3A-S3E; Tables S1 and S2 ). We sorted single aLP1 and aLP2 cells from both Notch-competent and -deficient FL and analyzed the expression of 81 genes. Among the sorted single cells, only cells that expressed the three housekeeping genes (Actb, Gapdh, and Hprt) and more than 10% of the 81 selected genes were considered ( Figure S4A ). Analysis of single-cell transcriptional expression allowed the identification of common signatures and key gene signatures that distinguish aLP1 from aLP2 cells. aLP1 and aLP2 share expression of ILC transcription factors such as Tox, Ets1, Id2, and Nfil3 and the absence of expression of specific B cell genes (Pax5 or Ebf1) ( Figure S4B ). aLP1 cells are enriched in cells expressing Notch1, Rag2, and Bcl11a, which are characteristics of T cell progenitors.
On the other hand, aLP2 cells mostly express Zbtb16, Rora, Tcf7, and Il2rb but have no expression of Rag2 and Bcl11a ( Figure S4C ). We have focused on the aLP2 subset analysis to avoid any T cell progenitor contaminant. After hierarchical clustering, we could define four clusters, based on the expression pattern of 43 discriminative genes regardless of the Notch deficiency. Using the Notch-competent condition as a control, we identified four groups of genes that could define specific transcriptional signatures ( Figure 4A ).
All clusters shared a core aLP2 gene signature composed of the expression of Itga4, Ets1, Notch2, Rora, Foxo1, Hif1a, Nfatc1, and Zbtb16 ( Figure 4B ). Cluster I (aLP2 I) is substantially different from other clusters, as it has a halved Id2-expressing cell frequency, with lower expression levels of Id2 by the few expressing cells ( Figure S4D ) and neither Tox nor Tcf7 expression, which are key transcription factors required for ILC development. In contrast, almost all cells in clusters II, III, and IV expressed those genes, along with Ahr, Il2rb, and Tnfrsf1a. Furthermore, cluster I displays a unique gene signature distinct from that of ILCs ( Figure 4C ).
Further discrimination of cluster II from clusters III and IV is based on the expression of Cxcr6 and Il18r1 ( Figure 4D ). Key molecules for LTi cell function, such as Lta, Ltb, and Cxcr5, are also highly enriched in clusters III and IV. In contrast, cluster II is mostly characterized by the expression of transcription factors Gata3, Nfil3, and Bcl11b, suggesting enrichment in the ILC2 progenitor transcriptional profile. Interestingly, Hes1, a target of Notch signaling, was found at high frequency in cluster II, suggesting a possible Notch activity in this subset.
Finally, cluster III is enriched in cells expressing key NK genes such as transcription factors Tbx21, Eomes, Irf1, and Irf8, whereas cells expressing Rorc, Bcl2, and Il1r1, key features of LTi or LTip cells, constitute cluster IV ( Figure 4E ). E15.5 FL lymphoid progenitors were tested for the presence of GATA3, T-bet, EOMES, and RORgt. Only GATA3 + and RORgt + cells were detected in the aLP2 fraction ( Figure S5A ).
Hence, the expression of both Tbx21 and Eomes mRNA show that specific mature ILC genes already have an accessible chromatin at the precursor stage. GATA3 is known to be necessary for the development of ILC3 and then could be considered as an ILC progenitor transcription factor (Serafini et al., 2014 Figures S5B-S5D) . Moreover, frequencies of the progeny obtained from the clonal assay suggest that aLP2 RORgt lo progenitors represent a heterogeneous compartment ( Figure S5D ). Hence, despite the expression of specific mature ILC transcripts, the FL aLP2 fraction is still heterogeneously composed of ILC progenitors.
In conclusion, we identified four subsets within the aLP2 fraction, each enriched in a specific ILC progenitor type. The clustering and the gene signatures suggest that the ''aLP2 I'' is enriched in Id2 À cells, representing a population of non-T/B progenitors. The ''aLP2 II'' represents ILC precursors with an enrichment in ILC2 fate, whereas ''aLP2 III'' is mainly constituted of NK progenitor cells, and the ''aLP2 IV'' mainly consists of LTi progenitors.
Heterogeneity of aLP2 Cells Reveals Different Priming toward ILC Lineages
To discriminate aLP2 subsets as defined previously, Thy1.2 and IL-18R1 expression were analyzed jointly with CXCR6 and ID2 expression due to Id2 yfp/+ Cxcr6 gfp/+ embryos.
The heterogeneous levels of ID2 in the aLP2 compartment (Figure 2D ) are in agreement with the single-cell assay showing diverse transcriptional levels of Id2 gene expression ( Figure 4C ; Figure S4 ). All ID2 À aLP2 cells are Thy1.2 À IL-18R1 lo ( Figure 5A Figure 5A ). Hence, the combination of Thy1.2 and IL-18R1 enables the ex vivo subdivision of aLP2 subsets in embryos that are not tagged for ID2 or CXCR6 ( Figure 5B ). As observed in Figure 5C , We assessed the clonal in vitro potential of the CLP, aLP1, and aLP2 fractions ( Figure 5C ( Figure 5D ). aLP2 I barely gave rise to any cells in culture conditions promoting lymphoid development. CLP and aLP1 subsets have a clonal efficiency of 40%, whereas aLP2 II Thy1.2 À or Thy1.2 + , III and IV have a clonal efficiency of 50% ( Figure 5E ). As suspected by the absence of Id2 gene expression and a specific gene signature, aLP2 I cells do not comprise ILC precursors.
CLPs mainly gave rise to T cells, with less than 5% of the progenitors that developed into ILCs alone. The aLP1 compartment retains T cell potential and could give rise to all ILC subsets, confirming our assumption from the transcriptome analysis that early ILC progenitors are represented in this fraction ( Figure S3 ). All ILCs could be detected within single clones at very low frequencies (less than 7%, with or without T cells; Figure 5F ). By using the sorting index, we observed that, among the aLP1 subset, ILC precursors are ID2 med a 4 b 7 hi , whereas T progenitors are ID2 À a 4 b 7 + (data not shown). The aLP2 compartments, as previously reported, had no T cell potential (Possot et al., 2011) . Interestingly, the subpopulations have distinctive ILC differentiation potentials ( Figure 5G Finally, aLP2 III/IV cells are enriched in RORgt + cells and then are biased toward ILC3, but they may also differentiate into ILC1.
In conclusion, we report that the aLP1 compartment, which contains a frequent tripotent ILC lineage precursor, is upstream of the aLP2 compartment. This latter can be subdivided in three subsets according to the surface expression of IL-18R1 and Thy1.2, and these subsets are differentially primed for differentiation toward each ILC lineage.
Notch Deficiency Differentially Affects aLP2 Subsets
We included and compared the Notch-deficient cells to our single-cell analysis to assess the extent of Notch activity in these compartments. Principal-component analysis (PCA) shows that within each cluster, Notch-competent and Notch-deficient cells are overlapping, suggesting that the major key gene signatures could still be found in the absence of Notch (Figures 6A and  6B ). We first studied the frequency of Id2 + over Id2 À progenitors in both genotypes and noticed that Id2 À progenitors showed a 2-fold increase in aLP1 and aLP2 after disruption of the Notch pathway ( Figures S6A and S6B ). Moreover, there was a clear effect of Notch disruption on the aLP2 II subset that decreased from 43% to 26% within the aLP2 compartment. In contrast, aLP2 I was increased (from 17% to 34%), whereas percentages of NKp and LTip (aLP2 III and IV) remained unaffected ( Figure 6C ). We further analyzed the expression pattern of aLP2 II to identify which genes are significantly affected by the deletion of Notch signaling in the remaining cells ( Figures 6D and 6E ). Hes1 is a well-known target of the Notch signaling. As expected, and Rora, which is a key factor of the aLP2 population. The analysis of the combined expression of key transcription factors (Rora, Gata3, Nfil3, Hes1, and Bcl11b) uncovers the loss of all cells expressing this set of genes after disruption of the Notch signaling. The few Tbx21-or Rorc-expressing cells that remain in this subset did not present the same combinatorial diversity as those found in Notch-competent FL ( Figure 6E ). In conclusion, Notch signaling is active in subset II of the aLP2 compartment.
We analyzed the aLP2 compartments of Notch-competent and -deficient E15.5 FL (Figures 6F and 6G ). As expected, no difference was observed in either aLP2 III/IV or aLP2 Thy1.2 À populations after Notch signaling disruption, and the aLP2 I population was increased. In contrast, aLP2 II Thy1.2 + was reduced by one third, confirming that the aLP2 subset is also Notch sensitive ex vivo.
Notch Signaling Acts on the Proliferation, but Not on the Differentiation, of the aLP2 II Thy1.2 + Subset Finally, we assessed whether Notch signaling could play a role in directing cells toward a given lineage. First, we cultured aLP1 (as control) and aLP2 fractions in short-term cultures with or without Notch inhibitor DAPT and analyzed the progeny, and then we measured their proliferation index ( Figures 7A-7C ). After 40 hr of culture, proliferation of aLP2 II Thy1.2 À and the aLP2 III/IV subset was not significantly affected. The aLP1 subset gave rise to more ILC precursors in the presence of DAPT, since the development toward the T cell pathway is inhibited ( Figure 7C ). Only the aLP2 II Thy1.2 + subset was affected by DAPT treatment, resulting in significantly less proliferation ( Figure 7C ).
We assessed whether Notch disruption would also affect the differentiation potential of each subset of aLP2 by clonal assays as previously described in Figure 5D . As expected, Notch-deficient aLP1 could not give rise to T cells ( Figure S7A ). aLP2 subsets have similar differentiation potential toward ILC1, ILC2, or ILC3, regardless of Notch signaling ( Figure S7B ). Figures 5D and S7B) . We then compared the clonal efficiencies of aLP1 and aLP2 subsets between Notch-competent and -deficient progenitors. With the exception of the aLP2 II Thy1.2 + subset that was reduced, no difference in the clonal efficiencies was observed for most aLP2 subsets ( Figure 7D ). Altogether, these results show that the proliferative capacity of the aLP2 II Thy1.2 + compartment is modulated by Notch signaling.
DISCUSSION
By combining clonal in vitro cultures and single-cell gene expression analyses, we determined the pathway of differentiation from the CLP to the different ILC subsets. The combined use of Flt3 and a4b7 already defined CLP, aLP1, and aLP2 (Possot et al., 2011) . Here, using ID2/CXCR6 reporter mice, we show that aLP1, while retaining T potential, comprises an all-ILC progenitor at a higher frequency than aLP2, mainly constituted of primed ILC precursors. Supporting this, aLP1 cells express mild levels of ID2. We propose that the GILP is phenotypically defined as Flt3 + ID2
med Tox + CXCR6 À in addition to the previous definition of a 4 b 7 -and Nfil3-expressing cells (Xu et al., 2015) . In the single-cell transcriptional analysis, the aLP1 subset encloses is in accordance with the recent finding that NFIL3 directs the Id2 expression through IL-7R signaling and control the ILC fate (Xu et al., 2015) . However, formal confirmation of the capacity of NFIL3 + cells to be ILC committed before expressing ID2 is still needed. From our single-cell experiment, we can assert that commitment toward the GILP takes place even earlier in the ID2 + fraction of aLP1.
TOX is also an important transcription factor for ILC lineage, since it is found in both aLP1 and aLP2 signatures. TOX-deficient mice lack LTi cells and are devoid of lymph nodes and Peyer's patches, and overexpression of ID2 did not rescue cNK development (Aliahmad et al., 2010) . According to a recent report (Seehus et al., 2015) , TOX has a role in the early commitment to the ILC fate. Similarly, we show that it is mainly co-expressed with Nfil3 and Id2 in aLP1 cells and further maintained in the aLP2 cells.
The transition to the aLP2 stage is accompanied by the decrease of the Flt3 expression and the presence of CXCR6 , 2011) . This subset is highly heterogeneous and was separated into four populations thanks to the clustering analysis that displayed diverse enrichment for the expression of the 81 investigated genes. The aLP2 transcriptional signature is defined by the upregulation of ILC-specific markers such as Notch2, Zbtb16, Rora, Tcf7, and Il2rb. Cluster I contains Id2 À progenitors with a quite specific profile different from that of other clusters. Despite the expression of Nfil3, these cells were essentially Tox À Tcf7
À

Il2rb
À and could not differentiate into lymphoid progeny. Thus, we excluded this cluster from the ILC precursor analysis. Using different strategies (clonal cultures and single-cell transcriptomics), we separated subfractions of aLP2 that were already primed for ILC lineages. Transcriptional profiles matched the preferential priming. For example, aLP2 III/IV that is CXCR6 + mainly give rise to ILC3 and, to some extent, ILC1, and it expresses Rorc (in protein and mRNA). It also expresses Tbx21 and Eomes transcripts. Notch2 levels increase from CLP to aLP2 fraction, inversely to Notch1 levels. Moreover, Notch2 expression is maintained in peripheral LTi cells (Possot et al., 2011; Cherrier et al., 2012) . Thus, we generated both Notch2-and Rbpj-deleted embryos in which the Notch pathway was conditionally deleted from the lymphoid progenitor stage, and we calculated that less than 1% of cells escaped the deletion.
CLP, aLP1, aLP2, and LTip fractions from FL were similar in percentage and numbers between Notch-deficient embryos and their control littermates, indicating that Notch signaling is not fundamental for their differentiation. In vitro cultures of Notch-deficient FL CLPs have demonstrated that they upregulate a 4 b 7 within 48 hr independently of Notch signaling. Similarly, the aLP1 and aLP2 precursors from both Notch-competent or -deficient embryos gave rise to identical progenies. A study suggested that Notch signaling must be interrupted after the a 4 b 7 + stage, since constitutive active Notch signaling results in a block at this precursor stage (Cherrier et al., 2012 (Dose et al., 2006; Schnell et al., 2006; Sharma et al., 2006) . On the contrary, Cdkn1c, a negative regulator of cell proliferation and a target of the Notch pathway, is significantly increased in these Notch-deficient Thy1.2 + ILC progenitors (Giovannini et al., 2012) . These results are compatible with a study in which progenitors cultured on OP9DL4 gave rise to larger numbers of ILC2 than on OP9 cell lines (Yang et al., 2015) .
In conclusion, we show that the Notch pathway is active in both aLP1 and aLP2 compartments, leading to changes in the transcriptional profile, abundance of Id2 + progenitors, and proliferation of Hes1 + progenitors in Notch-depleted, compared to Notch-competent, embryos. We defined new subsets that are differentially sensitive to the Notch pathway and clarify earlier contradictory in vitro observations. This comparative study indicates that, although it is not essential to the acquisition of a 4 b 7 , CXCR6, and RORgt expression by LTip, the Notch pathway is active at different stages along ILC differentiation and in the peripheral pool of LTi cells. Student's t test was used in (G); chi-square test was used in (D).
EXPERIMENTAL PROCEDURES Mice Il7r
Cre/+ Rosa26 YFP mice (Schlenner et al., 2010) 
Il7r
Cre/+ Rbpj fl/+ aLP1 (n = 264), aLP2 II Thy1.2 À (n = 232), aLP2 II Thy1.2 + (n = 137), and aLP2 III/IV (n = 186). In (C), each dot represents a single well from an experiment (two wells per experiment). Statistical data show mean ± SEM. *p < 0.05 (unpaired Student's t test). See also Figure S7 .
biotinylated-conjugated antibodies to lineage markers (CD3ε, CD19, CD11c, Ter119, Gr-1, NK1.1), followed by incubation with streptavidin microbeads (Miltenyi Biotec). Depletion was done on LS Columns (Miltenyi Biotec), from which the negative fraction was recovered.
Flow Cytometry and Cell Sorting
Flow cytometry data were acquired using a BD FACSCanto II or BD LSRFortessa (Becton Dickinson) and analyzed with FlowJo software (Tree Star). Dead cells were eliminated by propidium iodide exclusion. Cells were stained intracellularly after permeabilization and fixation with Foxp3 Transcription Factor Fixation/Permeabilization Concentrate and Diluent (eBioscience). FL, FS, and FmLN cells were purified with a FACSAria III (Becton Dickinson). Cells were recovered in Eppendorf tubes or directly in 96-well qPCR plates for gene expression analysis.
Antibodies
All antibodies were from BD Biosciences, eBioscience, BioLegend, Cell Signaling Technology, or R&D Systems.
Antibodies either biotinylated or conjugated to various fluorochromes were used against the following mouse antigens: Ly76 (TER-119), Gr-1 (RB6-8C5), CD11c (HL3), CD3 (145-2C11), CD19 (6D5), NK1.1 (PK136), IL-7Ra (A7R34), c-Kit (2B8), Sca-1 (D7), RORgt (AFKJS-9), a 4 b 7 (DATK32), Flt3 (A2F10), CD8 (53-6.7), TCRb (H57-597), CCR6 (29-2L17), CD4 (GK1.5), CD25 (PC61), CD44 (IM7), IL-18R1 (BG/IL18RA), and Thy1.2 (53-2.1).
Cell Culture
All experiments were done in 96-well plates at 37 C and 5% CO 2 and in culture medium consisting of OptiMEM, 10% (v/v) FCS, penicillin (100 U/ml), streptomycin (100 mg/ml) and 2-mercaptoethanol (5 3 10 À7 M; GIBCO). OP9 and OP9-DL4 stromal cells were seeded into 96-well plates (1,000 cells per well). The culture medium was supplemented with saturating amounts of c-Kit ligand, Flt3 ligand, IL-2, and IL-7 made ''in house.'' In some experiments, DAPT was added (20 mM, Sigma), with DMSO as control. CLP, aLP1, and aLP2 differentiation potentials were assayed by flow cytometry after 48 hr, 8 days, or 12 days of culture on OP9 or OP9-DL4 stroma.
RT-PCR
Cells were sorted in RLT Buffer (QIAGEN) and were frozen at À80 C. RNA was obtained with an RNeasy Micro Kit (QIAGEN), and cDNA was obtained with a PrimeScript RT Reagent Kit (Takara). A 7300 Real-Time PCR System (Applied Biosystems) and TaqMan technology (Applied Biosystems) or SYBRGreen technology (QIAGEN) were used for RT qPCR. A bilateral unpaired Student's t test was used for statistical analysis. The following primers were from SABiosciences: Il17a, PPM03023A; Il17f, PPM05398E; Il22, PPM481A; and Gapdh, PPM02946E.
The following primers were from Applied Biosystems: Gata3, Mm00484683; Id2, Mm00711781; Tox, Mm00455231_m1; Hes1, Mm00468601_m1; Hprt1, Mm00446968; Rbpj, Mm01217627_g1; Rora, Mm01173766_m1; Rorc, Mm012 61022_m1; Dtx1, Mm00492297_m1; Nrarp, Mm00482529_s1; Tcf7, Mm00 493445_m1; Notch1, Mm00435249_m1; and Notch2, Mm00803069_m1.
The following primers were custom produced by Invitrogen: Cd3e forward: 5 0 -GCCTCAGAAGCATGATAAGC-3 0 / Cd3e reverse: 5 0 -CCTTGGCCTTCCT ATTCTTG-3 0 .
Biomark Cells were sorted in 96-well qPCR plates in 10 ml of the CellsDirect One-Step qRT-PCR Kit (Thermo Fisher Scientific), containing a mix of diluted primers (0.053 final concentration; see Tables S1 and S2 ). Preamplified cDNA was obtained after reverse transcription (15 0 at 40 C, 15 0 at 50 C and 15 0 at 60 C) and preamplification (22 cycles: 15 00 at 95 C, 4 0 at 60 C) and was diluted 1:5 in TE Buffer[pH 8] (Ambion). Sample mix was as follows: diluted cDNA (2.9 ml), Sample Loading Reagent (0.29 ml, Fluidigm), TaqMan Universal PCR Master Mix (3.3 ml, Applied Biosystems) or Solaris qPCR Low ROX Master Mix (3.3 ml, GE Dharmacon). Assay mix was as follows: Assay Loading Reagent (2.5 ml, Fluidigm), TaqMan (2.5 ml, Applied Biosystems) or Solaris (2.5 ml, GE Dharmacon Samples that did not express at least one of three housekeeping genes (Actb, Gapdh, or Hprt) were removed from analysis. Data were processed through the MeV (MultiExperiment Viewer) Software (TM4). Hierarchical clustering was performed on C T values of each gene analyzed from single cells, using uncentered Pearson's correlation with absolute distance and total linkage. PCA was performed to cluster samples.
Statistical Analyses
Statistical data show mean ± SEM. The chi-square test and unpaired Student's t test were used.
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